Exagen Inc President & CEO, Ron Rocca Interview with TodaysStocks.com Host, Pat Bolland

TodaysStocks.com news host Pat Bolland interviews CEO Ron Rocca from Exagen Inc.     Exagen (NASDAQ: XGN) is a leading provider of autoimmune diagnostic, prognostic, and monitoring testing solutions.  Exagen is a patient focused, discovery driven organization built on the success of AVISE testing and is investing in its product pipeline to support patients throughout their autoimmune diagnosis and treatment. Exagen’s goal is to assist patients, physicians, and payors by enabling precision medicine. Exagen is located in San Diego County with clinical and research and development laboratories in Vista, CA.  Ron Rocca and Pat Bolland's discussion was centred on the Exagen Inc press release dated July 5, 2022 https://stockmkt.info/3yOyPzK  0:16 CAPSTONE Study  0:56 1st finding  1:14 2nd finding  1:58 3rd finding  2:30 4th finding  2:43 5th finding  3:00 Size of study  3:30 How long does the study take  4:45 Business side of things   Learn more about Exagen Inc. on their website www.Exagen.com